Sarcoma Clinical Trials
Sarcoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for sarcoma. Corterve aggregates actively recruiting Sarcoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Sarcoma studies
- Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaNCT05711615PHASE1National Cancer Institute (NCI)Los Angeles, California
- Novel Biochemical and Molecular Determinants for Soft Tissue SarcomaNCT00579566Memorial Sloan Kettering Cancer CenterBasking Ridge, New Jersey
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerNCT00006518National Cancer Institute (NCI)Bethesda, Maryland
- Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...NCT02390752PHASE1National Cancer Institute (NCI)Bethesda, Maryland
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological StudiesNCT01109394National Cancer Institute (NCI)Washington D.C., District of Columbia
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsNCT07628634EARLY_PHASE1University of California, IrvineOrange, California
- Natural History Study of Kaposi SarcomaNCT06375122National Cancer Institute (NCI)Bethesda, Maryland
- Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1NCT06083883PHASE1M.D. Anderson Cancer CenterHouston, Texas
- A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)NCT07466316PHASE3Children's Oncology GroupLos Angeles, California
- A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingNCT06066138PHASE1National Cancer Institute (NCI)Bethesda, Maryland
- Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasNCT06422806PHASE3National Cancer Institute (NCI)Phoenix, Arizona
- A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic TherapyNCT07633756PHASE1M.D. Anderson Cancer CenterHouston, Texas
Sarcoma trials by state
Sarcoma trials by metro
Frequently asked questions
- How do I find recruiting Sarcoma clinical trials?
- Corterve aggregates actively recruiting Sarcoma studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Sarcoma clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Sarcoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.